The trade-off is that Tesamorelins approval is narrow: it applies specifically to HIV-associated lipodystrophy, not general fat loss, and its GH-axis mechanism carries monitoring requirements around IGF-1 and glucose that AOD-9604s trials did not show
BPC 157 reduces immediate and delayed damage induced brain trauma and improves nerve regeneration after transection
Mechanism of Action In research applications CJC-1295 (No DAC) acts as a GH releasing factor analog that will increase the secretion of GH by mimicking the function of endogenous GHRH, and Ipamorelin acts to selectively bind the ghrelin receptor to initiate another pathway of increased growth hormone production
The B12 Injection is 1 injection in your arm takes 1 minute
However, BPC 157 is a therapeutic agent not approved by the FDA, which cites risk of immunogenicity, peptide-related impurities, and limited safety-related information as reasons for banning BPC-157
Engelke UF, van Outersterp RE, Merx J, van Geenen FA, van Rooij A, Berden G, et al